Sever Pharma Solutions Announces Appointment of New VP of Quality
Sever Pharma Solutions (SPS) is pleased to announce the appointment of Niklas Lindgren as the company’s new Vice President of Quality, effective January 19, 2026. The appointment was announced by Fredrik Hultenuis, CEO of Sever Pharma Solutions.
Niklas brings more than three decades of experience in quality management, regulatory compliance, and manufacturing operations within the pharmaceutical and medical device industries. His most recent role was Vice President QA/RA and Operations at Dignitana, a medical device company specializing in innovative cooling systems designed to reduce chemotherapy-induced hair loss.
Prior to his role at Dignitana, Niklas spent over 20 years with Baxter International Inc, where he held several senior leadership positions. During his final decade at Baxter, he served as Site Manager QA for the Lund facility and Quality Management Representative, with responsibility for overseeing critical quality operations and driving key compliance initiatives.
Throughout his extensive career, Niklas has built deep expertise in quality systems and regulatory compliance, working in highly regulated global environments across both pharmaceuticals and medical devices.
“Niklas brings a wide experience across both quality management and production,” said Fredrik Hultenuis. “His deep expertise, leadership capabilities, and strong industry background make him an excellent addition to our leadership team”
Sever Pharma Solutions looks forward to the contributions Niklas will bring as he steps into this important role.
